1. Home
  2. SMCI vs ROIV Comparison

SMCI vs ROIV Comparison

Compare SMCI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super Micro Computer Inc.

SMCI

Super Micro Computer Inc.

HOLD

Current Price

$28.47

Market Cap

20.1B

Sector

Technology

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$29.88

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMCI
ROIV
Founded
1993
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.1B
20.7B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
SMCI
ROIV
Price
$28.47
$29.88
Analyst Decision
Hold
Strong Buy
Analyst Count
18
9
Target Price
$34.69
$28.94
AVG Volume (30 Days)
41.5M
4.1M
Earning Date
05-05-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.86
N/A
Revenue
$2,484,929,000.00
$29,053,000.00
Revenue This Year
$92.37
N/A
Revenue Next Year
$21.47
$744.61
P/E Ratio
$32.99
N/A
Revenue Growth
11.68
N/A
52 Week Low
$19.48
$10.01
52 Week High
$62.36
$30.33

Technical Indicators

Market Signals
Indicator
SMCI
ROIV
Relative Strength Index (RSI) 58.41 64.59
Support Level $19.48 $20.46
Resistance Level $33.17 $30.33
Average True Range (ATR) 1.33 0.90
MACD 0.93 0.17
Stochastic Oscillator 91.09 91.84

Price Performance

Historical Comparison
SMCI
ROIV

About SMCI Super Micro Computer Inc.

Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, high-performance computing, and the Internet of Things embedded markets. Its solutions include servers, storage systems, modular blade servers, workstations, full-rack scale solutions, networking devices, server sub-systems, and server management. These turn-key solutions are designed, developed, validated, and installed for AI datacenters. The company has one operating segment that develops and provides high-performance server solutions based upon a, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: